Health Catalyst (NASDAQ:HCAT) reported Q4 EPS of ($0.05), $0.06 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $69.2 million versus the consensus estimate of $68.26 million.
GUIDANCE:
Health Catalyst sees Q1 2023 revenue of $70.3-72.3 million, versus the consensus of $71.6 million.
Health Catalyst sees FY2023 revenue of $290-295 million, versus the consensus of $298.7 million.